Angiotensin II signal transduction in vascular smooth muscle: Pathways activated by specific tyrosine kinases

Journal of the American Society of Nephrology

Volumn 10, Issue 1 SUPPL. 11, 1999, Pages

  Berk, Bradford C ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GENISTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE;

ATHEROSCLEROSIS; CONGESTIVE HEART FAILURE; DRUG RECEPTOR BINDING; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; RECEPTOR DENSITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0032907677     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Skeggs LT Jr, Marsh WH, Kahn JR, Shumway NP: The purification of hypertensin I. J Exp Med 100: 363-370, 1954
2. Berk BC, Vekshtein V, Gordon HM, Tsuda T: Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13: 305-314, 1989
3. Geisterfer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62: 749-756, 1988
4. 2 in cultured rat mesangial cells. Am J Physiol 253: C113-C120, 1987
5. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activation in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994
6. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE: Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375: 247-250, 1995
7. 2+ mobilization and protein kinase C activation. J Biol Chem 264: 526-530, 1989
8. SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293-302, 1991
9. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial. N Engl J Med 327: 669-677, 1992
10. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351: 233-235, 1991
11. Sasaki K, Yamamo Y, Bardham S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin type-1 receptor. Nature 351: 230-232, 1991
12. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ: Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 268: 24539-24542, 1993
13. Huckle WR, Prokop CA, Dy RC, Herman B, Earp S: Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner. Mol Cell Biol 10: 6290-6298, 1990
14. Huckle WR, Dy RC, Earp HS: Calcium-dependent increase in tyrosine kinase activity stimulated by angiotensin II. Proc Natl Acad Sci USA 89: 8837-8841, 1992
15. Molloy CJ, Taylor DS, Weber H: Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem 268: 7338-7345, 1993
16. Zohn IE, Yu H, Li X, Cox AD, Earp HS: Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase. Mol Cell Biol 15: 6160-6168, 1995
17. Hollenberg MD: Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 15: 108-114, 1994
18. Leduc I, Haddad P, Giasson E, Meloche S: Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells. Mol Pharmacol 48: 582-592, 1995
19. Pascal SM, Singer AU, Gish G, Yamazaki T, Shoelson SE, Pawson T, Kay LE, Forman K-JD: Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. Cell 77: 461-472, 1994
20. Fantl WJ, Johnson DE, Williams LT: Signalling by receptor tyrosine kinases. Annu Rev Biochem 62: 453-481, 1993
21. Ali MS, Schieffer B, Delafontaine P, Bernstein KE, Ling BN, Marrero MB: Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein-tyrosine phosphatase 1D in vascular smooth muscle cells. J Biol Chem 272: 12373-12379, 1997
22. Ali MS, Sayeski PP, Dirksen LB, Hayzer DJ, Marrero MB, Bernstein KE: Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor. J Biol Chem 272: 23382-23388, 1997
23. Tanner FC, Noll G, Boulanger CM, Luscher TF: Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries: Role of scavenger receptor and endothelium-derived nitric oxide [see comments]. Circulation 83: 2012-2020, 1991
24. Pleiman CM, Clark MR, Gauen LK, Winitz S, Coggeshall KM, Johnson GL, Shaw AS, Cambier JC: Mapping of sites on the Src family protein tyrosine kinases p55blk, p59fyn, and p56lyn which interact with the effector molecules phospholipase C-gamma 2, microtubule-associated protein kinase, GTPase-activating protein, and phosphatidylinositol 3-kinase. Mol Cell Biol 13: 5877-5887, 1993
25. Darnell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421, 1994
26. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O: Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 19: 222-227, 1994
27. Bhat GJ, Thekkumkara TJ, Thomas WG, Conrad KM, Baker KM: Angiotensin II stimulates sis-inducing factor-like DNA binding activity. J Biol Chem 269: 31443-31449, 1994
28. Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN: Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 272: 24684-24690, 1997
29. Rodriguez-Linares B, Watson SP: Phosphorylation of JAK2 in thrombin-stimulated human platelets. FEBS Lett 352: 335-338, 1994
30. Bolen JB, Rowley RB, Spana C, Tsygankov AY: The Src family of tyrosine protein kinases in hemopoietic signal transduction. FASEB J 6: 3403-3409, 1992
31. c-src in vascular smooth muscle cells. Circ Res 77: 1053-1059, 1995
32. c-src antibodies inhibits the angiotensin II activation of phospholipase C-γ1 in rat aortic smooth muscle cells. J Biol Chem 270: 15734-15738, 1995
33. Ishida M, Ishida T, Thomas S, Berk BC: Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 82: 7-12, 1998
34. Paigen B, Mitchell D, Reue K, Morrow A, Lusis AJ, LeBoeuf RC: Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci USA 84: 3763-3767, 1987
35. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J: Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery [see comments]. J Clin Invest 92: 883-893, 1993
36. Sadoshima J, Izumo S: The heterotrimeric Gq protein-coupled angiotensin II receptor activates p21ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 15: 775-787, 1996
37. Polte TR, Naftilan AJ, Hanks SK: Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II. J Cell Biochem 55: 106-119, 1994
38. Okuda M, Kawahara Y, Nakayama I, Hoshijima M, Yokoyama M: Angiotensin II transduces its signal to focal adhesions via angiotensin II type 1 receptors in vascular smooth muscle cells. FEBS Lett 368: 343-347, 1995
39. cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase. J Biol Chem 271: 13649-13655, 1996
40. Sabe H, Hata A, Okada M, Nakagawa H, Hanafusa H: Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. Proc Natl Acad Sci USA 91: 3984-3988, 1994
41. Yamaguchi R, Maki M, Hatanaka M, Sabe H: Unphosphorylated and tyrosine-phosphorylated forms of a focal adhesion protein, paxillin, are substrates for calpain II in vitro: Implications for the possible involvement of calpain II in mitosis-specific degradation of paxillin. FEBS Lett 356: 114-116, 1994
42. FAK accompanies cell adhesion to extracellular matrix: A role in cytoskeletal assembly. J Cell Biol 119: 893-903, 1992
43. Leduc I, Meloche S: Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem 270: 4401-4404, 1995
44. Turner CE, Pietras KM, Taylor DS, Molloy CJ: Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J Cell Sci 108: 333-342, 1995
45. Eguchi S, Matsumoto T, Motley ED, Utsunomiya H, Inagami T: Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells: Possible requirement of Gq-mediated p21ras activation coupled to a Ca2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 271: 14169-14175, 1996
46. Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, Schlessinger J: Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature 376: 737-745, 1995
47. Sasaki H, Nagura K, Ishino M, Tobioka H, Kotani K, Sasaki T: Cloning and characterization of cell adhesion kinase β, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J Biol Chem 270: 21206-21219, 1995
48. Yu H, Li X, Marchetto GS, Dy R, Hunter D, Calvo B, Dawson TL, Wilm M, Anderegg RJ, Graves LM, Earp HS: Activation of a novel calcium-dependent protein-tyrosine kinase. J Biol Chem 271: 29993-29998, 1996
49. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J: A role for Pyk2 and src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383: 547-550, 1996
50. Brinson AE, Harding T, Diliberto PA, He Y, Li X, Hunter D, Herman B, Earp HS, Graves LM: Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor. J Biol Chem 273: 1711-1718, 1998
51. Murasawa S, Mori Y, Nozawa Y, Gotoh N, Shibuya M, Masaki H, Maruyama K, Tsutsumi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Iwasaka T, Inada M, Matsubara H: Angiotensin AT1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by a Ca2+/Calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res 82: 1338-1348, 1998
52. Linseman DA, Benjamin CW, Jones DA: Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem 270: 12563-12568, 1995
53. Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A: Signal characteristics of G protein-transactivated EGF receptor. EMBO J 16: 7032-7044, 1997
54. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T: Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273: 8890-8896, 1998
55. Li X, Lee JW, Graves IM, Earp HS: Angiotensin II stimulates ERK via two pathways in epithelial cells: Protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway. EMBO J 17: 2574-2583, 1998
56. Stitt TN, Conn G, Gore M, Lai C, Bruno J, Radziejewski C, Mattsson K, Fisher J, Gies DR, Jones PF, Masiakowski P, Ryan TE, Nancy JT, Chen DH, DiStefano PS, Long GL, Basiico C, Goldfarb MP, Lemke G, Glass DJ, Yancopoulos GD: The anti-coagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Ax1 family of receptor tyrosine kinases. Cell 80: 661-670, 1995
57. Li R, Chen J, Hammonds G, Phillips H, Armanini M, Wood P, Bunge R, Godowski PJ, Sliwkowski MX, Mather JP: Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci 16: 2012-2019, 1996
58. Ling L, Kung HJ: Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase. Mol Cell Biol 15: 6582-6592, 1995
59. 2+-mobilizing growth factors. J Biol Chem 270: 5702-5705, 1995
60. Fridell YW, Jin Y, Quilliam LA, Burchert A, McCloskey P, Spizz G, Varnum B, Der C, Liu ET: Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Ax1 receptor tyrosine kinase. Mol Cell Biol 16: 135-145, 1996
61. Melaragno MG, Wuthrich DA, Poppa V, Gill D, Lindner V, Berk BC, Corson MA: Increased expression of Ax1 tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circ Res 83: 697-704, 1998
62. Marrero MB, Schieffer B, Ma HP, Bernstein KE, Ling BN: ANG II-induced tyrosine phosphorylation stimulates phospholipase C-gamma 1 and C1(-) channels in mesangial cells. Am J Physiol 39: C1834-C1842, 1996
63. Wijetunge S, Aalkjaer C, Schachter M, Hughes AD: Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 189: 1620-1623, 1992
64. Wijetunge S, Hughes AD: Activation of endogenous c-Src or a related tyrosine kinase by intracellular (pY)EEI peptide increases voltage-operated calcium channel currents in rabbit ear artery cells. FEBS Lett 399: 63-66, 1996